• 08-Dec-2025 (Monday): Installed development tools including IntelliJ IDEA and Eclipse IDE. • 09-Dec-2025 (Tuesday): Began learning Java fundamentals and core concepts. • 10-Dec-2025 (Wednesday): ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dhurandhar is one of the most-awaited films of 2025 that has been garnering a lot of attention ever since it was announced. The trailer and posters created so much hype, fans cannot wait for the film ...

This is this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Click here to get on the ...

Recursion Pharmaceuticals stock jumped 16% on October 8, 2025, reaching around $6.08 after falling 5.4% the previous day on broader market weakness. The company reported Q2 2025 revenue of $19.2 ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

SACHIN ADITYA NARAYAN RANJAN VERMA bearing DIN number 09248063 is currently the director of NARAYAN BUILDEX INFRA LIMITED, JAPAS ALLIANCE INDIA PRIVATE LIMITED. SACHIN ADITYA NARAYAN RANJAN VERMA was ...

An illustration of a magnifying glass. An illustration of a magnifying glass.